Canada · Funded startup

Who invested in Aurinia Pharmaceuticals

3 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$255Mraised across 3 rounds since 2014, from 3 sources

$52MRound$200MRound$3.1MRound
Latest round
Round, $3.1MJun 2026
Biggest round
$200MRound · Jul 2020
Investors
9
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2014201620182020202220242026
$52MRound$200MRound$3.1MRound
First round
Round, $52M
Feb 2014
Biggest round
$200M
Round · Jul 2020
Usual gap between rounds
6.3 years
the median of 2

The rounds

  1. Jun 2026
    Round$3.1M3 returning

    Source recorded

  2. Jul 2020
    Round$200M3 returning

    Source recorded

  3. Feb 2014
    Round$52M9 new

    From a historical funding recordSEC filing: $52M sold, first sale Feb 2014

Founders and team

From Aurinia Pharmaceuticals's own website: 5 on the team.

  • Kevin TangChair of the Board and Chief Executive Officer
  • Michael HearneChief Financial Officer
  • Ryan ColeChief Operating Officer
  • Stew KrollChief Development Officer
  • Thomas WeiChief Scientific Officer

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2014Round2020Round2026New Enterprise AssociatesRA Capital ManagementRedmile GroupLumira VenturesApple Tree PartnersvenBio PartnersGreat Point PartnersDifference CapitalILJIN Life Science

Everyone who backed them

New Enterprise AssociatesVC firm3rounds
RA Capital ManagementPrivate equity3rounds
Redmile GroupVC firm3rounds
Lumira VenturesVC firm1round
Apple Tree PartnersVC firm1round
venBio PartnersVC firm1round
Great Point PartnersPrivate equity1round
Difference CapitalVC firm1round
ILJIN Life ScienceInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Aurinia Pharmaceuticals

Who invested in Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals's investors include New Enterprise Associates, RA Capital Management, Redmile Group, Lumira Ventures and Apple Tree Partners, and 4 more on record.

How much has Aurinia Pharmaceuticals raised?

Aurinia Pharmaceuticals has raised $255M across 3 rounds since 2014.

When did Aurinia Pharmaceuticals last raise?

Aurinia Pharmaceuticals's most recent round was an Undisclosed round of $3.1M in Jun 2026.

What was Aurinia Pharmaceuticals's biggest round?

Aurinia Pharmaceuticals's largest round on record is $200M (Undisclosed round), in Jul 2020.

Who backed Aurinia Pharmaceuticals first?

Aurinia Pharmaceuticals's first round on record, in Feb 2014, was backed by New Enterprise Associates, RA Capital Management and Redmile Group and 6 others.

What stage is Aurinia Pharmaceuticals at?

Aurinia Pharmaceuticals's latest named round is an Undisclosed round, in Jun 2026.

Where is Aurinia Pharmaceuticals based?

Aurinia Pharmaceuticals is based in Canada.

Companies like Aurinia Pharmaceuticals

In the same sector, and raised in the last eighteen months.

VoxCell$2.2M · Sept 2026Launch Bioindustries$646K · Sept 2026Lobe Sciences$1.0M · Jun 2026ZYUS$505K · May 2026CELYSTRA Pharma$15M · May 2026Stoked Bio$366K · May 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app